Integrative Analysis of Ferroptosis-related Genes in Ulcerative Colitis
Overview
Affiliations
Objective: The aim of this study was to identify and validate ferroptosis-related markers in ulcerative colitis (UC) to explore new directions for UC diagnosis and treatment.
Methods: We screened UC chips and ferroptosis-related genes from the Gene Expression Omnibus (GEO), FerrDb, and GeneCards databases. The differentially expressed genes (DEGs) and ferroptosis-related DEGs between the UC group and normal controls were analyzed using bioinformatics methods. Enrichment analysis, protein-protein interaction analysis, and hub genes were screened. Peripheral blood chip and animal experiments were used to validate the ferroptosis-related hub genes. Finally, hub gene-transcription factor, hub gene-microRNA (miRNA), and hub gene-drug interaction networks were constructed.
Results: Overall, 26 ferroptosis-related DEGs were identified that were significantly enriched in energy pathways and metabolism. We identified ten ferroptosis-related hub genes from the protein-protein interaction network: , , , , , , , , , and . In the peripheral blood chip GSE94648, and were upregulated, which was consistent with the expression trend in GSE75214. Animal experiments showed that expression was significantly increased in the colon.
Conclusions: Our findings indicate that and may be ferroptosis-related markers in UC.
Bao X, Chen Y, Chang J, Du J, Yang C, Wu Y BMC Cancer. 2025; 25(1):273.
PMID: 39955536 PMC: 11830216. DOI: 10.1186/s12885-025-13658-3.
Zhang X, Zheng G, Zhou Z, Zhu M, Tang S Heliyon. 2024; 10(17):e37517.
PMID: 39290263 PMC: 11407083. DOI: 10.1016/j.heliyon.2024.e37517.
Lan J, Deng Z, Wang Q, Li D, Fan K, Chang J Int J Biol Sci. 2024; 20(7):2507-2531.
PMID: 38725846 PMC: 11077368. DOI: 10.7150/ijbs.94548.
Liu X, Qiao D, Zhang Y, Liu Z, Chen Y, Que R World J Clin Cases. 2024; 12(10):1750-1765.
PMID: 38660076 PMC: 11036473. DOI: 10.12998/wjcc.v12.i10.1750.
Deciphering Ferroptosis: From Molecular Pathways to Machine Learning-Guided Therapeutic Innovation.
Mete M, Ojha A, Dhar P, Das D Mol Biotechnol. 2024; .
PMID: 38613722 DOI: 10.1007/s12033-024-01139-0.